Synbiotic formula shows promise in reducing long COVID symptoms

Study finds that the synbiotic preparation SIM01 significantly reduces post-acute COVID-19 syndrome symptoms in patients, including fatigue, memory issues, and gastrointestinal distress, indicating its potential as a treatment for long COVID.

Henrietta Lacks settlement hailed by experts as step toward correcting medicine’s racist history

For what would have been Henrietta Lacks’s 103th birthday, her family got her some justice: A settlement with Thermo Fisher Scientific over the Massachusetts-based company’s

August 1, 2023

Kronos Bio axes nearly one-fifth of staff to preserve cash for two cancer programs

Kronos Bio is downsizing its workforce by 19% as part of broader restructuring efforts meant to save cash, so that the company can continue work

November 4, 2023

Lykos upheaval continues with four new board exits amid hunt for cash

Four Lykos Therapeutics board members have stepped down, and another departed last month, in the aftermath of a stalemate over how to finance the psychedelic

January 15, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.